Vivien Beziat

Title: Vivien Beziat: Innovator in Immunotherapy

Introduction

Vivien Beziat is a prominent inventor based in Huddinge, Sweden. She has made significant contributions to the field of immunotherapy, particularly through her innovative approaches to natural killer (NK) cell expansion. Her work is paving the way for advancements in therapeutic applications.

Latest Patents

Vivien Beziat holds a patent for her invention titled "Selective and controlled expansion of educated NK cells." This patent relates to methods for obtaining cytolytic differentiated NKG2A+NKG2C+ cells with specific KIR specificity. The disclosed methods not only have therapeutic applications but also non-therapeutic uses, showcasing the versatility of her research.

Career Highlights

Vivien Beziat is associated with Inven2, a company that focuses on the commercialization of research innovations. Her work at Inven2 has allowed her to further develop her ideas and bring them to fruition in the field of immunotherapy.

Collaborations

Vivien collaborates with Karl-Johan Malmberg, a fellow researcher in the field. Their partnership enhances the potential for groundbreaking discoveries in immunotherapy.

Conclusion

Vivien Beziat's contributions to immunotherapy through her innovative patent and collaboration with esteemed colleagues highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic techniques.